The association between Polycystic Ovary Syndrome (PCOS) and metabolic syndrome: A statistical modelling approach

Clinical Endocrinology

Volumn 83, Issue 6, 2015, Pages 879-887

  Ranasinha, S ^a   Joham, A E ^a,b   Norman, R J ^c   Shaw, J E ^d   Zoungas, S ^a   Boyle, J ^a   Moran, L ^a,c   Teede, H J ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b SOUTHERN HEALTH   (Australia)

^c UNIVERSITY OF ADELAIDE   (Australia)

^d BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; INSULIN; LIPID;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERANDROGENISM; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; OBESITY; OBSERVATIONAL STUDY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STATISTICAL MODEL; AUSTRALIA; METABOLISM; PHYSIOLOGY;

ADULT; AUSTRALIA; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INSULIN RESISTANCE; METABOLIC SYNDROME X; MODELS, STATISTICAL; OBESITY; POLYCYSTIC OVARY SYNDROME; RETROSPECTIVE STUDIES;

EID: 84936806150     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12830     Document Type: Article

References (35)

1. March, W.A., Moore, V.M., Willson, K.J., et al,. (2010) The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria. Human Reproduction, 25, 544-551.
2. Yildiz, B.O., Bozdag, G., Yapici, Z., et al,. (2012) Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria. Human Reproduction, 27, 3067-3073.
3. Teede, H., Misso, M., Deeks, A., et al,. (2011) Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline. Medical Journal of Australia, 195, S65-S112.
4. panel NEbw (2012). NIH Evidence based workshop on Polycystic Ovary Syndrome. http://preventionnihgov/workshops/2012/pcos/resourcesaspx
5. Stepto, N.K., Cassar, S., Joham, A.E., et al,. (2013) Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp. Human Reproduction, 28, 777-784.
6. Teede, H.J., Joham, A.E., Paul, E., et al,. (2013) Longitudinal weight gain in women identified with polycystic ovary syndrome: Results of an observational study in young women. Obesity, 21, 1526-1532.
7. Kiddy, D.S., Sharp, P.S., White, D.M., et al,. (1990) Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome-an analysis of 263 consecutive cases. Clincal Endocrinology (Oxford), 32, 213-220.
8. Diamanti-Kandarakis, E., &, Papavassiliou, A.G., (2006) Molecular mechanisms of insulin resistance in polycystic ovary syndrome. Trends in Molecular Medicine, 12, 324-332.
9. Cussons, A.J., Watts, G.F., Burke, V., et al,. (2008) Cardiometabolic risk in polycystic ovary syndrome: A comparison of different approaches to defining the metabolic syndrome. Human Reproduction, 23, 2352-2358.
10. Grundy, S.M., Brewer, H.B. Jr, Cleeman, J.I., et al,. (2004) Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation, 109, 433-438.
11. Ehrmann, D.A., Liljenquist, D.R., Kasza, K., et al,. (2006) Prevalence and predictors of the metabolic syndrome in women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism, 91, 48-53.
12. The IDF consensus worldwide definition of the metabolic syndrome. International Diabetes Federation (IDF); Belgium, 2006.
13. Alberti, K.G., Eckel, R.H., Grundy, S.M., et al,. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation, 2009; 120: 1640-1645.
14. Bonora, E., (2006) The metabolic syndrome and cardiovascular disease. Annals of Medicine, 38, 64-80.
15. Moran, L.J., Misso, M.L., Wild, R.A., et al,. (2010) Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Human Reproduction Update, 16, 347-363.
16. O'Reilly, M.W., Taylor, A.E., Crabtree, N.J., et al,. (2014) Hyperandrogenemia predicts metabolic phenotype in polycystic ovary syndrome: the utility of serum androstenedione. The Journal of Clinical Endocrinology & Metabolism, 99, 1027-1036.
17. Dabadghao, P., Roberts, B.J., Wang, J., et al,. (2007) Glucose tolerance abnormalities in Australian women with polycystic ovary syndrome. Medical Journal of Australia, 187, 328-331.
18. Barr, E., Magliano, D., Zimmet, P., et al,. (2006). The Australian Diabetes, Obesity and Lifestyle Study. International Diabetes Institute, Melbourne.
19. Dunstan, D.W., Zimmet, P.Z., Welborn, T.A., et al,. (2002) The rising prevalence of diabetes and impaired glucose tolerance: the Australian Diabetes Obesity and Lifestyle Study. Diabetes Care, 25, 829-834.
20. Dunstan, D.W., Zimmet, P.Z., Welborn, T.A., et al,. (2002) The Australian Diabetes, Obesity and Lifestyle Study (AusDiab)-methods and response rates. Diabetes Research and Clinical Practice, 57, 119-129.
21. Shen, B.J., Todaro, J.F., Niaura, R., et al,. (2003) Are metabolic risk factors one unified syndrome? Modeling the structure of the metabolic syndrome X. American Journal of Epidemiology, 157, 701-711.
22. Woolston, A., Tu, Y.K., Baxter, P.D., et al,. (2012) A comparison of different approaches to unravel the latent structure within metabolic syndrome. PLoS ONE, 7, e34410.
23. Gambineri, A., Pelusi, C., Vicennati, V., et al,. (2002) Obesity and the polycystic ovary syndrome. International Journal of Obesity, 26, 883-896.
24. Meyer, C., McGrath, B.P., &, Teede, H.J., (2005) Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease. Journal of Clinical Endocrinology & Metabolism., 90, 5711-5716.
25. Eckel, R.H., Grundy, S.M., &, Zimmet, P.Z., (2005) The metabolic syndrome. Lancet, 365, 1415-1428.
26. Holte, J., Gennarelli, G., Berne, C., et al,. (1996) Elevated daytime blood pressure in women with polycystic ovary syndrome: a sign of a pre-hypertensive state? Human Reproduction, 11, 23-28.
27. Lim, S.S., Davies, M.J., Norman, R.J., et al,. (2012) Overweight, obesity and central obesity in women with polycystic ovary syndrome: a systematic review and meta-analysis. Human Reproduction Update, 18, 618-637.
28. Pasquali, R., Gambineri, A., &, Pagotto, U., (2006) The impact of obesity on reproduction in women with polycystic ovary syndrome. BJOG, 113, 1148-1159.
29. Hutchison, S.K., Stepto, N.K., Harrison, C.L., et al,. (2011) Effects of exercise on insulin resistance and body composition in overweight and obese women with and without polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism, 96, E48-E56.
30. Balen, A.H., Conway, G.S., Kaltsas, G., et al,. (1995) Polycystic ovary syndrome: the spectrum of the disorder in 1741 patients. Human Reproduction, 10, 2107-2111.
31. Gateva, A.T., &, Kamenov, Z.A., (2012) Markers of visceral obesity and cardiovascular risk in patients with polycystic ovarian syndrome. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 164, 161-166.
32. Forrester-Dumont, K., Galescu, O., Kolesnikov, A., et al,. (2012) Hyperandrogenism does not influence metabolic parameters in adolescent girls with PCOS. International Journal of Endocrinology, 2012, 1-5. doi: 10.1155/2012/434830.
33. Corbould, A., (2008) Effects of androgens on insulin action in women: is androgen excess a component of female metabolic syndrome? Diabetes/Metabolism Research and Reviews, 24, 520-532.
34. Moran, L.J., Teede, H.J., Noakes, M., et al,. (2013) Sex hormone binding globulin, but not testosterone, is associated with the metabolic syndrome in overweight and obese women with polycystic ovary syndrome. Journal of Endocrinological Investigation, 36, 1004-1010.
35. Nestler, J.E., &, Jakubowicz, D.J., (1997) Lean women with polycystic ovary syndrome respond to insulin reduction with decreases in ovarian P450c17 alpha activity and serum androgens. Journal of Clinical Endocrinology and Metabolism, 82, 4075-4079.